APOB-48 SHOWS POTENTIAL AS A BIOMARKER TO EVALUATE TREATMENT RESPONSE WITH APRAGLUTIDE IN SHORT BOWEL SYNDROME, INTESTINAL FAILURE AND COLON-IN-CONTINUITY

Sep 14, 2025 — 04:20 pm - 4:30 PM
Panorama Hall

Oral Communication
Presenter:
Astrid VERBIEST

Parent session